Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cardiology Advisor
The Wegovy tablet is the first oral GLP-1 receptor agonist indicated for weight loss and cardiovascular risk reduction in eligible adults.
Endocrinology & Diabetes Nursing March 13th 2026
GoodRx for Healthcare Professionals
If approved, retatrutide will be the first in a new class of medications combining GIP, GLP-1, and glucagon receptor agonism in a single once-weekly injection.
Endocrinology, Diabetes, Metabolism March 13th 2026
Therapeutic Advances in Musculoskeletal Disease
Early treatment phases may transiently promote immune activation, whereas sustained therapy, by reducing BMI and lowering systemic inflammation, may mitigate this effect.
Cardiology March 13th 2026
Epoch Health
“The most striking changes rarely show up first in lab results; they show up in how people feel on Tuesday afternoon and Thursday night.” – Sheridan Genrich, nutritionist
Endocrinology, Diabetes, Metabolism January 27th 2026
Journal of Clinical Nursing (JCN)
Nurse-led clinics are, in most cases, commensurate with standard care; however, they provide more time with patients leading to greater satisfaction.
Family Medicine/General Practice January 23rd 2026
Medical Professionals Reference (MPR)
“The pharmacist should have realized that the prescription was incorrectly written and should have communicated with the provider, who would have then understood that the titration schedule was incorrect, and all this wouldn’t have happened.”
Clinical Pharmacology December 11th 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS